2025-05-22 06:01:36 pm | Source: reuters
India`s Sun Pharma posts quarterly profit rise on strong demand for rare disease drugs
Sun Pharmaceutical, India's largest drugmaker by revenue, reported a rise in adjusted quarterly profit on Thursday, driven by strong domestic demand for its drugs to treat rare diseases.
The Mumbai-based firm's consolidated profit before exceptional items and tax rose 24% to 36.16 billion rupees ($420.7 million) in the three months ended March 31.
Disclaimer:
The content of this article is for informational purposes only and should not be considered financial or
investment advice. Investments in financial markets are subject to market risks, and past performance is
not indicative of future results. Readers are strongly advised to consult a licensed financial expert or
advisor for tailored advice before making any investment decisions. The data and information presented
in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the
content of this article for any current or future financial references.
To Read Complete Disclaimer Click Here
Latest News
Technical Forecast 17th November 2025 by Vaishali Pa...
Financials Banks Sector Update :Ground Zero - Channe...
Sell Silver Dec @ 157000 SL 158500 TGT 155500-154200...
Nifty immediate support is at 25800 then 25750 zones...
Sell Gold Dec @ 124200 SL 125200 TGT 123000-122000. ...
Jr Women Academy C`ship: Ghumanhera Riser?s, Raja Ka...
Norway, Portugal book FIFA World Cup 2026 spots
Stock Option OI Report 17th November 2025 by Nirmal ...
EAM S Jaishankar to meet Russian counterpart in Mosc...
Market Watch: Event filled week greets Nifty by Geoj...
